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M A J O R A R T I C L E
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Fabienne Tacchini-Cottier,3 and Pascal Launois1,3
1Immunologie des Leishmanioses, Institut Pasteur de la Guyane, and 2Institut Guyanais de Dermatologie Tropicale, Equipe d’Accueil 2188,
Centre Hospitalier Andre´e Rosemon, Cayenne, French Guyana; 3World Health Organization Immunology Research and Training Centre,
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland
Peripheral blood mononuclear cells from subjects never exposed to Leishmania were stimulated with Leish-
mania guyanensis. We demonstrated that L. guyanensis–stimulated CD8+ T cells produced interferon (IFN)–
g and preferentially expressed the Vb14 T cell receptor (TCR) gene family. In addition, these cells expressed
cutaneous lymphocyte antigen and CCR4 surface molecules, suggesting that they could migrate to the skin.
Results obtained from the lesions of patients with localized cutaneous leishmaniaisis (LCL) showed that Vb14
TCR expression was increased in most lesions (63.5%) and that expression of only a small number of Vb gene
families (Vb1, Vb6, Vb9, Vb14, and Vb24) was increased. The presence of Vb14 T cells in tissue confirmed
the migration of these cells to the lesion site. Thus, we propose the following sequence of events during
infection with L. guyanensis. After initial exposure to L. guyanensis, CD8+ T cells preferentially expressing the
Vb14 TCR and secreting IFN-g develop and circulate in the periphery. During the infection, these cells migrate
to the skin at the site of the parasitic infection. The role of these Vb14 CD8+ T cells in resistance to infection
remains to be determined conclusively.
The clinical outcome of infection with Leishmania de-
pends on the infective agents and the specific immune
response to Leishmania antigens. Cutaneous leishman-
iasis is characterized by several clinical, histopatho-
logical, and immunological features; however, the
immunopathogenesis of different forms of dermal
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leishmaniasis is poorly understood, and the mecha-
nisms leading to resistance to the various Leishmania
species are not well defined.
The description of functional CD4+ T helper (Th)
cell subsets provided a rational basis for the differen-
tiation of responses elicited by CD4+ T cells during
pathogenesis. CD4+ T cells differentiate into 2 func-
tionally distinct subsets, Th1 and Th2, distinguishable
by the mutually exclusive patterns of the cytokines that
they produce after reactivation. In an experimental mu-
rine model of infection with Leishmania major, a cor-
relation was found between resistance to infection and
the development of a CD4+ Th1 response and between
susceptibility to infection and the development of a
CD4+ Th2 response [1–3]. However, this murine model
does not mimic human dermal leishmaniasis, which
presents distinct clinical and immunological profiles.
Thus, with regard to human infection, identification of
the specific T cell populations that contribute to pro-
tective or resistant immune responses is important.
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Table 1. Clinical data for patients with LCL.
Patient Lesions, no. Location of lesion(s)
Development of
lesion(s), daysa Adenopathy Lymphangitis Status of lesion(s)
1 2 Wrist 50 No No Healing
2 1 Lower limbs 50 No No Healing
3 1 Elbow 55 No No Healing
4 3 Neck 60 No No Healing
5 1 Lower limbs 75 No No Not healing
6 2 Foot 105 No No Not healing
7 4 Lower limbs 150 No No Healing
8 2 Foot 40 No No Healing
9 2 Upper limbs 35 No No Healing
10 1 Lower limbs 30 No No Healing
11 6 Face 15 No No Healing
a Duration of lesion before patient sought care.
T cells that recognize foreign antigens track a specific T cell
receptor (TCR). The study of the TCR repertoire may con-
tribute to the understanding of disease pathogenesis. In this
study, we analyzed the Vb TCR repertoire by using Leishmania
guyanensis–stimulated T cells from naive subjects. We showed
that interferon (IFN)–g–producing CD8+ T cells selectively ex-
press the Vb14 TCR gene family. Furthermore, these cells ex-
press cutaneous lymphocyte antigen (CLA) and CCR4 mole-
cules, suggesting that they are able to migrate to skin lesions.
The preferential expression of the Vb14 TCR in the lesions of
patients with localized cutaneous leishmaniaisis (LCL) supports
this hypothesis. The presence of Vb14+ CD8+ T cells in lesions
was not associated with healing but was correlated with a lon-
ger duration of lesions.
MATERIALS AND METHODS
Samples. Blood samples were obtained, by venipuncture,
from 11 patients with active American cutaneous leishmaniasis
caused by L. guyanensis, before specific treatment, and were
collected into sterile tubes (Veinoject, Terumo). Biopsy speci-
mens were obtained from the border of the healthy skin (5
mm), and all parts of the biopsy were processed. Clinical data
for these patients are given in table 1. All patients were sero-
negative for human immunodeficiency virus. Blood samples
from 5 healthy subjects who had never been exposed to Leish-
mania also were included in this study. Absence of prior ex-
posure to Leishmania was assessed as described elsewhere [4].
Informed consent was obtained from the subjects, and guide-
lines issued from the Comite´ Consultatif de Protection des
Personnes dans la Recherche Me´dicale of Guadeloupe were
followed (project no. 99-3).
Antigens. L. guyanensis (M4147) promastigotes were cul-
tured in biphasic rabbit blood agar [5]. Extracellular proteins
were removed from the parasite pellets by means of 3 washes
with PBS. Parasites were used at 106 parasites/mL. Whole M.
bovis bacille Calmette-Gue´rin (BCG; strain GL2) was used at
5 mg/mL.
Reagents. The reagents for magnetic cell separation using
anti-CD8 or anti-CD4 monoclonal antibodies (mAbs) were ob-
tained from Dynal. Mouse anti-human mAbs CD3 (UTCHT1,
IgG1), CCR4 (1C1, IgG1), CD62L (Dreg56, IgG1), and CCR7
(2H4, IgM) and rat anti-human CLA (HECA-452, IgM) were
obtained from Pharmingen.
Lymphocyte cultures. Peripheral blood mononuclear cells
(PBMCs) were isolated, after venipuncture, on a Ficoll-Hy-
paque gradient ( ) and were resuspended in RPMIdp 1.077
supplemented with 2 mmol/L glutamine, 100 U/mL penicillin,
and 1 mg/mL streptomycin (all from Sigma) and 5% human
heat-inactivated AB serum (EFS Ile de France). Cultures for
cytokine production (106 cells in 1 mL of culture medium)
were plated on flat-bottomed 24-well plates with or without
antigens. After 5 days, cells were harvested for analysis of Vb
TCR gene expression.
CD4+ and CD8+ T cells were purified with anti-CD4 and
anti-CD8 magnetic beads, in accordance with the manufac-
turer’s instructions (Dynal). This resulted in a population of
92% CD8 and 95% CD4 T cells, as determined by fluorescence-
activated cell-sorter (FACS) analysis. For restimulation of Vb14
and Vb1 cells, Vb-positive cells were purified by use of a mag-
netic activated cell sorter from Dynal. In brief, PBMCs were
stimulated for 5 days with L. guyanensis. Then, the cells were
conjugated with an anti-Vb14 or anti-Vb1 TCR, incubated with
anti-mouse immunoglobulin-coated magnetic microbeads, and
isolated by exposure to a magnetic field. Purity was 92%, as
determined by FACS analysis. Positively selected T cells were
resuspended in medium, at 105 cells/mL, in the presence of
mytomicin-treated autologous PBMCs ( cells), for use65 10
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Table 2. Analysis of expression of Vb T cell receptor (TCR)
genes in peripheral blood mononuclear cells (PBMCs) stim-
ulated with live Leishmania guyanensis or whole bacille Cal-
mette-Gue´rin (BCG; as controls), from subjects never ex-
posed to Leishmania.
Vb TCR gene
L. guyanensis–stimulated
PBMCs, by subject
BCG-stimulated
PBMCs, by subject
1 2 3 4 5 1 2 3 4
1
2 
3   
4
5.1  
5.2/5.3
6.1/6.2/6.3  
6.5/6.8/6.9
6.6/6.7 
7
8
9 
10 
11   
12 
13.1 
13.2
14   
15
16  
17 
18 
19 
20 
21 
22
23  
24
NOTE. Blackened boxes indicate a ratio 12 for the percentage of Vb
expression in stimulated PBMCs divided by the percentage of Vb ex-
pression in unstimulated PBMCs.
as antigen-presenting cells, and L. guyanensis (106 parasites/mL)
and were further cultured for 72 h. SNs were collected, and
IFN-g production was analyzed by use of a specific IFN-g
ELISA (Pharmingen).
Flow cytofluorometric analysis of IFN-g–producing CD8+
T cells. PBMCs were cultured in the presence of live L. guy-
anensis or whole BCG; after 5 days, CD8+ T cells were purified
as described by the manufacturer (Dynal). In brief, cells con-
jugated with an anti-CD8 mAb were incubated with anti-mouse
IgG-coated magnetic microbeads and, subsequently, were iso-
lated after exposure to a magnetic field. Purity was 96%, as
determined by FACS analysis. CD8 mAb was released with
Detachabeads, as described by the manufacturer (Dynal). Pu-
rified CD8+ T cells were labeled first with various anti-human
antibodies and incubated for 30 min at 4C. Anti-mouse IgG
or IgM conjugated with fluorescein isothiocyanate (Sigma) was
added, and the cells were incubated for 20 min at 4C. As
human anti-CLA was produced, as IgM from rat, an inter-
mediate step with mouse anti-rat was added.
The IFN-g–secreting cells were isolated from these purified,
labeled CD8+ T cells by use of an IFN-g–secretion assay kit, in
accordance with the manufacturer’s instructions (Miltenyi Bio-
tec). In brief, a rat anti–IFN-g mAb (rat IgG1) conjugated to
cell surface–specific mAb (mouse IgG2) (i.e., the IFN-g catch
reagent) was attached to the cell surface of CD8+ T cells. Cells
then were incubated for 45 min at 37C, and secreted IFN-g
bound to the IFN-g catch reagent on the secreting cells. Then,
the cytokine was labeled with an IFN-g–detecting mAb con-
jugated to phycoerythrin (PE; mouse IgG1). Finally, the IFN-
g–secreting CD8+ T cells were purified by use of anti-PE mi-
crobeads. Analysis was done on a FACSscan cell sorter (Becton
Dickinson) using Cell Quest software (Becton Dickinson).
RNA extraction from PBMCs and biopsy specimens. Total
RNA was isolated from either PBMCs, purified CD8+ and CD4+
T cells, or biopsy specimens, as described elsewhere [6]. First-
strand cDNA synthesis was done on total RNA, by use of a first-
strand cDNA synthesis kit (Amersham-Pharmacia Biotech).
Polymerase chain reaction (PCR) amplification of Vb TCR
mRNA. Vb TCR mRNA amplification was performed by use
of 28 oligonucleotide primers specific for individual Vb gene-
segment families or for Vb family members combined with a
consensus Cb primer recognizing sequences conserved between
the Cb1 and Cb2 genes, as described elsewhere [7]. The PCR
conditions were denaturation for 30 s at 94C and annealing/
extension for 1 min at 65C, for 35 cycles.
ELISA-based quantification of PCR products. Quantifi-
cation of PCR products was done by use of the PCR-ELISA
method described elsewhere [7], using 2 probes specific for
Cb1 (5′-GAAAAACGTGTTCCACCCGAGGTCGCCC-3′) and
Cb2 (5′-GAACAAGGTGTTCCCACCCGAGGTCGCCC-3′) to
detect Vb TCR by means of reverse-transcriptase (RT) PCR.
The 28 Vb TCR mRNA RT-PCR products were run in trip-
licate wells in the same ELISA plate, and average optical density
(OD) values were obtained for each Vb gene family. The OD
measured for each Vb gene family was divided by the total OD
measured in the repertoire. The percentage of the total Vb
repertoire for each Vb gene family in tissue was divided by the
percentage of the total Vb repertoire of the same Vb gene family
in stimulated PBMCs and was expressed as the tissue/PBMC
ratio. The percentage of the total Vb repertoire for each Vb
gene family in stimulated PBMCs was divided by the percentage
of the total Vb repertoire of the same Vb gene family in un-
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Table 3. Analysis of expression of Vb T cell receptor (TCR)
genes in purified CD4+ and CD8+ T cells stimulated with live
Leishmania guyanensis, from subjects never exposed to
Leishmania.
Vb TCR gene
CD4+ T cells,
by subject
CD8+ T cells,
by subject
1 2 3 4 1 2 3 4
1
2
3 
4
5.1 
5.2/5.3
6.1/6.2/6.3
6.5/6.8/6.9
6.6/6.7
7
8
9
10
11
12
13.1
13.2
14   
15
16 
17
18
19
20 
21
22
23
24
NOTE. Blackened boxes indicate a ratio 12 for the percentage of
Vb expression in stimulated purified T cells divided by the percentage
of Vb expression in unstimulated purified T cells.
stimulated PBMCs and was expressed as the PBMCs ratio. A
ratio 12 was considered to indicate increased expression of the
Vb gene family.
RESULTS
Expression of the Vb14 TCR chain in L. guyanensis–specific
T cells in naive subjects. We had demonstrated previously
the existence of L. guyanensis–specific CD8+ T cells that produce
IFN-g in PBMCs from healthy subjects never exposed to Leish-
mania [8]. Thus, we investigated whether this CD8+ T cell
population showed oligoclonal specificities, by determining the
Vb repertoire in these cells. The RT-PCR–ELISA detection
method was used [7] to analyze the relative expression of 28
Vb gene families in L. guyanensis–stimulated PBMCs from sub-
jects who had never been exposed to Leishmania infection.
The mean percentage of the total Vb repertoire for each Vb
gene family was not significantly different within unstimulated
T cells from naive subjects (data not shown). The percentage
of the total Vb repertoire for each Vb gene family in stimulated
PBMCs was divided by the percentage of the total Vb repertoire
of the same Vb gene family in unstimulated PBMCs from 5
subjects never exposed to Leishmania. A ratio 12 was considered
to indicate increased expression of the Vb gene family. As
shown in table 2, the expression of different TCR gene families
was increased in L. guyanensis–stimulated PBMCs from naive
subjects, when compared with that in unstimulated PBMCs.
Although PBMCs stimulated with L. guyanensis showed in-
creased expression of at least 1 of the Vb TCR gene families
(such as Vb3, Vb5.1, Vb6.6/6.7, Vb11, Vb16, Vb17, and Vb20)
in 1 naive subject, Vb14 showed increased expression in PBMCs
stimulated with live L. guyanensis in 3 of the 5 naive subjects
analyzed. As a control, the Vb repertoire of cells stimulated
with whole BCG was analyzed. PBMCs stimulated with BCG
showed increased expression of 114 Vb TCR gene families that
did not include Vb14. Together, these results demonstrate that
the increase of Vb14 TCR expression in PBMCs from naive
subjects is specific to L. guyanensis stimulation.
To confirm that cells expressing the Vb14 TCR gene after
stimulation with L. guyanensis were CD8+ T cells, we isolated
CD4+ and CD8+ T cells, stimulated them with L. guyanensis,
and analyzed the expression of their Vb TCR repertoire. As
shown in table 3, CD8+ T cells stimulated with L. guyanensis
increased expression of the Vb14 TCR gene in 3 of 4 naive
subjects analyzed. In L. guyanensis–stimulated CD4+ T cells, we
detected an increase of Vb3, Vb5.1, Vb16, and Vb20 TCR gene
expression.
To confirm that the CD8+ T cells producing IFN-g in re-
sponse to stimulation with L. guyanensis expressed the Vb14
TCR gene family, we enriched the IFN-g–secreting CD8+ T
cells obtained at the end of the culture, by using the IFN-g–
secretion assay kit, and analyzed the expression of the Vb TCR
repertoire in these cells. Results from individual amplification
of Vb gene families in cells stimulated and in those not stim-
ulated with L. guyanensis are shown in figure 1 for 2 of the 3
naive subjects analyzed. Stimulation of PBMCs from 2 naive
subjects (subjects 3 and 4 from table 2) showed restricted Vb14
expression in subject 3 and restricted Vb14 and increased
Vb6.6/6.7 expression in subject 4. In contrast, we were unable
to detect increased expression of Vb TCR genes in IFN-g–
secreting cells from subject 2 (data not shown).
In addition, Vb14 cells were purified from PBMCs stimulated
with L. guyanensis for 5 days and restimulated with L. guyanensis
for an additional 3 days, after which IFN-g production was
measured. Purified Vb14 cells produced higher amounts of
Figure 1. Expression of the Vb14 T cell receptor (TCR) gene family in interferon (IFN)–g–producing CD8+ T cells in subjects who have never been exposed to Leishmania. For amplification of the Vb
gene families in IFN-g–producing cells, IFN-g–secreting cells were enriched from unstimulated or Leishmania guyanensis (L.g.)–stimulated peripheral blood mononuclear cells, by use of the IFN-g–
secretion assay kit, and expression of the different Vb gene families was analyzed as described in Materials and Methods. Percentage of the Vb repertoire represents the optical density (OD) measured
for each Vb gene family amplification divided by the sum of the total OD for all Vb genes measured in the repertoire and expressed as the percentage of the total repertoire. Subjects 3 and 4 are the
same as in table 1. Arrows indicate significant differences between unstimulated and L. guyanensis–stimulated cells.
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Figure 2. Homing capacity of interferon (IFN)–g–producing CD8+ T cells from subjects who have never been exposed to Leishmania. Peripheral
blood mononuclear cells (PBMCs) were cultured as described in Materials and Methods. After 5 days of culture, CD8+ T cells were purified from
PBMCs with anti-CD8 magnetic beads (Dynal). Purified CD8+ T cells were first labeled with various purified anti-human monoclonal antibodies (anti–
cutaneous lymphocyte antigen [CLA], anti-CCR4, and anti-CD62L), and anti-mouse IgG or IgM conjugated with fluorescein isothiocyanate (Sigma) was
added. Because human anti-CLA is a rat IgM, an intermediate step with anti-rat was added. IFN-g–secreting cells and cells not secreting IFN-g were
isolated from these CD8+ T cells by use of an IFN-g –secretion assay kit, as described in Materials and Methods. A, Stimulation with Leishmania
guyanensis. B, Stimulation with whole bacille Calmette-Gue´rin.
IFN-g than did Vb1 cells in response to secondary stimulation
with L. guyanensis ( and pg/mL, respec-1675 240 345 265
tively). As a control, IFN-g production in all cells (including
all TCR-expressing cells) in response to stimulation with L.
guyanensis was measured ( pg/mL). Together, these3240 125
results demonstrate that IFN-g–producing CD8+ T cells from
subjects who have never been exposed to Leishmania prefer-
entially express the Vb14 TCR gene family in response to L.
guyanensis stimulation.
Migration to the skin of IFN-g–producing CD8+ T cells that
express the Vb14 TCR chain. The homing capacity of the
IFN-g–producing CD8+ T cells was assessed by measurement
of their expression of CLA and the receptors of the CC che-
mokines (CCR4), which drive the migration of T cells to the
skin [9, 10]. In addition, the surface expression of CD62L,
which is necessary for migration to lymph nodes [11], was
evaluated. By combining the trapping of IFN-g–producing
CD8+ T cells, through use of the IFN-g–secretion assay kit at
the end of the culture, and the analysis of the expression of
the above-mentioned markers at the surface of these cells, we
showed that IFN-g–secreting CD8+ T cells expressed the CLA
and CCR4 molecules (figure 2A). As a control, cells that did
not produce IFN-g (IFN-g–negative cells) were analyzed and
did not express CLA, CCR4, and CD62L (figure 2A), dem-
onstrating that the increased expression of these molecules did
not result from the culture conditions. Furthermore, after BCG
stimulation, IFN-g–producing cells expressed CD62L at high
levels but did not express CLA (figure 2B). Together, these
results suggest that, in response to live L. guyanensis, IFN-g–
producing cells are potentially able to migrate to the skin at
the site of Leishmania infection.
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Table 4. Analysis of expression of Vb T cell receptor (TCR) genes in leishmaniasis lesions.
Vb TCR gene
Patient
Patients, %1 2 3 4 5 6 7 8 9 10 11
1      45.5
2 0
3  9.1
4  9.1
5.1  9.1
5.2/5.3 0
6.1/6.2/6.3    27.3
6.5/6.8/6.9   18.2
6.6/6.7   18.2
7  9.1
8 0
9    27.3
10  9.1
11 0
12 0
13.1   18.2
13.2   18.2
14        63.5
15 0
16 0
17 0
18 0
19 0
20   18.2
21 0
22 0
23 0
24    27.3
NOTE. Blackened boxes indicate a ratio 12 for the percentage of Vb expression in lesions divided by the percentage
of Vb expression in Leishmania guyanensis–stimulated peripheral blood mononuclear cells.
Increase of Vb14 TCR expression in lesions due to L. guy-
anensis infection. To confirm that IFN-g–producing T cells
preferentially expressing the Vb14 TCR gene migrate to the
skin, we determined the Vb repertoire in lesion samples from
patients with LCL. We compared the relative expression of each
Vb gene family in the tissue samples with that in live L. guy-
anensis–stimulated PBMCs from patients with cutaneous leish-
maniasis. For the 11 patients analyzed, the expression of several
Vb gene families was increased in tissue. As shown in table 4,
expression of Vb14 was increased in 7 (63.5%) of 11 patients,
suggesting that the IFN-g–producing CD8+ T cells effectively
migrated to the skin. Furthermore, expression of the Vb1 and
Vb6 TCR gene families was increased in lesions from 5 (45.5%)
of the 11 patients with LCL, and Vb9 and Vb24 expression
was increased in 3 (27.3%) of the 11 patients. For all patients,
expression of at least 1 Vb gene family was increased in tissue,
when compared with TCR gene expression in PBMCs stimu-
lated with live L. guyanensis. Only a small number (1–3) of Vb
gene families were overrepresented in most patients.
Association between increased Vb14 TCR expression in L.
guyanensis–infected tissue and a longer duration of lesions.
We analyzed the correlation between the increase of Vb14 TCR
expression in tissue and clinical data (tables 1 and 4). We found
no association between overexpression of the Vb14 TCR gene
and the number of lesions and/or location. Furthermore, no
association was detected between the healing status of the le-
sions and the expression of Vb14. Although the 2 patients who
presented with unresolving lesions (patients 5 and 6) had in-
creased Vb14 TCR expression, 4 of 9 patients who presented
with healing lesions did not have increased Vb14 TCR ex-
pression. However, we found that increased expression of the
Vb14 TCR gene in tissue was associated with the duration of
lesion development: in tissue in which the Vb14 TCR gene was
overexpressed, the duration of lesion development was longer
than that in tissue with normal expression of Vb14 (median
of 60 days vs. 32.5 days, respectively) (figure 3). As a control,
the increased expression of Vb6 and Vb1 TCR genes in tissue
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Figure 3. Length of evolution of lesions in biopsy samples, with respect
to increased Vb expression in lesion samples. Results are given as in-
dividual plots and median days of the development of lesions with either
overexpression of a particular Vb T cell receptor (TCR) chain (Vb+) or
normal expression of a particular Vb TCR chain (Vb). Overexpression
of a particular Vb gene was evaluated as in figure 2.
was analyzed and could not be associated with the duration of
lesions.
DISCUSSION
In this study, we demonstrated preferential Vb14 TCR expression
in IFN-g–producing CD8+ T cells in L. guyanensis–stimulated
PBMCs from naive subjects. The expansion of cells from naive
subjects never exposed to Leishmania has been described else-
where. It has been reported that PBMCs from unexposed subjects
may produce IFN-g in response to Leishmania aethiopica stim-
ulation and that NK cells and CD8+ T cells are the source of this
IFN-g [12, 13]. Furthermore, we had demonstrated previously
the presence of IFN-g–producing CD8+ T cells in L. guyanensis–
stimulated PBMCs from naive subjects [8].
We hypothesized that Vb14+ CD8+ T cells are able to migrate
to the skin to mount their antiparasitic functions. Thus, we
investigated the expression of CLA and CCR4 on the IFN-g–
producing CD8+ T cells specific for L. guyanensis. By combining
the trapping of specific IFN-g–producing CD8+ T cells and the
analysis of the expression of these surface markers, we were
able to demonstrate the expression of CCR4 and CLA on these
cells, suggesting that these cells can migrate to the skin.
We then measured the diversity of the Vb chain TCR rep-
ertoire in lesions caused by L. guyanensis. We found that, al-
though the expression of only a small number of Vb gene
families was increased in tissue samples, Vb14 was predominant
in the lesions of 63.5% of patients with LCL; Vb1 and Vb6
were predominant in 45% of patients, and Vb13 and Vb24
were predominant in 27% of patients. In accordance with our
data, a recent report showed a decrease of Vb14 expression in
CD8+ T cells in the lymph nodes of patients with LCL who
were infected with Leishmania braziliensis, which may reflect
the sequestration of such cells at the site of infection [14].
The fact that the expression of a limited number of Vb TCR
gene families is increased in biopsy specimens from patients
with LCL implies the recognition of a limited number of an-
tigens. This result is surprising given the high complexity of
the Leishmania parasite and the recognition of a high number
of antigens from Leishmania by the PBMCs of patients with
LCL. However, our results are in agreement with those of pre-
vious reports showing the dominance of a limited set of Vb
TCR gene families in lesions caused by other pathogens, such
as L. braziliensis [15], Wucheria bancrofti [7], or Mycobacterium
leprae [16]. We report here that, at the site of infection in
patients with LCL, a population of cells preferentially expresses
the Vb14 TCR gene family, a TCR gene that also is expressed
in IFN-g–producing CD8+ T cells specific for L. guyanensis, in
PBMCs from naive subjects.
Because the expression of a particular Va chain on the Vb14+
CD8+ T cells and the diversity of the CDR3 region have not
been evaluated, it is not possible to assess whether cells ex-
pressing the Vb14 TCR gene family at the site of infection and
PBMCs stimulated with L. guyanensis recognize the same an-
tigen. Furthermore, although we have demonstrated that Vb14-
expressing cells in PBMCs from naive subjects are CD8+ T cells,
the phenotype of the Vb14-expressing cells in tissue samples
is unknown. However, because CD8+ T cells have been iden-
tified in lesions caused by L. guyanensis infection [17], we can
assume that the Vb14-expressing cells in tissue could be CD8+
T cells. Purification of CD8+ T cells from tissue samples should
confirm this hypothesis. Unfortunately, the number of CD8+
T cells recovered from tissue samples did not allow us to analyze
their Vb repertoire. However, the fact that the Vb14-expressing
cells in naive subjects express markers of migration to the skin
suggests that the Vb14 detected in tissue samples indicates mi-
grating Vb14 cells.
With regard to the association between the overexpression
of a particular Vb TCR gene family and clinical data, we were
unable to detect an association with the number of lesions or
location or with the healing status of the lesions. Thus, the
Vb14+ CD8+ T cells did not appear to significantly contribute
to the resolution of infection. However, we cannot rule out
that the effect of the IFN-g produced by the Vb14+ T cells is
down-regulated by cytokines produced by cells within the le-
sion. In a previous study, we described the production of in-
terleukin-10 by L. guyanensis–stimulated PBMCs from patients
with LCL [18]. Nevertheless, the increase of Vb14 TCR gene
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expression in lesions was associated with the duration of lesions.
The duration of lesion development in patients showing in-
creased Vb14 TCR expression in tissue was longer than that
measured in patients with normal Vb14 expression.
Other skin diseases also have been studied for the nature and
function of clonally expanded T cells. In this context, it is in-
teresting to note that Vb14 overexpression was reported in lesions
of human bancroftian filariosis [7]. The Vb6 TCR gene family
was shown to be dominant in the lesions of patients infected
with L. braziliensis [15] and in tuberculoid leprosy lesions [16].
Recent data have indicated that the Vb12 TCR gene also may
be involved in the response to L. braziliensis [14].
Several studies have analyzed the Vb TCR repertoire in nor-
mal human skin. Two of them have reported overexpression
of the Vb6 gene family [19, 20], and a third study has reported
overexpression of the Vb14 gene family [21]. Because Vb6 and
Vb14 are overexpressed in tissue samples from most patients
with LCL, we cannot rule out that Leishmania could have stim-
ulated T cells already localized in the skin. Unfortunately, in
the present study, for ethical reasons we were unable to obtain
normal tissue samples to evaluate expression of the Vb TCR
repertoire in T cells in skin. However, the expression of CCR4
and CLA on L. guyanensis–specific T cells producing IFN-g, as
well as the expression of Vb14 in infected tissue, suggests that
L. guyanensis–specific T cells migrate actively to the skin during
chronic cutaneous infection.
In summary, CD8+ T cells preferentially expressing the Vb14
TCR gene and secreting IFN-g develop and circulate in the
periphery. These cells migrate to the skin at the site of parasitic
infection. However, the exact role of these cells in resistance to
infection remains to be firmly established.
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